Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Saptak Chem and Business Limited has submitted its 46th Annual Report for FY 2024-25 to BSE in compliance with SEBI Listing Regulations. The company reported negligible revenue of Rs. 0.06 lacs and widened its loss to Rs. 8.62 lacs, compared to a loss of Rs. 3.48 lacs in FY 2023-24, with accumulated losses standing at Rs. 1,298.90 lacs. No dividend was declared for the year. The company received NCLT approval on June 23, 2025 for a 90% capital reduction, cutting equity shares from 1,07,32,272 to 10,73,227 shares of Rs. 10 each. The 46th AGM is scheduled for August 30, 2025 via video conferencing, with key items including adoption of FY25 financial statements and re-appointment of Managing Director Mr. Rohitkumar Parikh.
This is a routine annual report filing, but the near-zero revenue, consecutive losses, and the drastic 90% capital reduction point to serious financial difficulties. Existing shareholders have seen their equity stake effectively restructured, and there is no near-term sign of operational recovery.